Related Articles
Development, efficacy and side effects of antibody‑drug conjugates for cancer therapy (Review)
Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review)
MUC13 promotes lung cancer development and progression by activating ERK signaling
Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma
Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreatic cancer